GlassScriptPhysician profile
Thomas Joseph Mcnamee
NPI 1891753083
$2,683.95
in general payments reported to CMS, 2019-2025
20 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what 84% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.09 · 2021: $94.51 · 2022: $323 · 2023: $442 · 2024: $792 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,157 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,157.25 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $1,144.52 | 2022-2025 | Slynd, Tyblume |
| Astellas Pharma US INC | $341.95 | 2023-2025 | Veozah |
| Abbvie INC. | $261.76 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $233.56 | 2022-2025 | |
| Exact Sciences Corporation | $114.83 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $93.00 | 2022-2025 | Nuvaring, Nexplanon |
| Sumitomo Pharma America, INC. | $81.02 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $80.55 | 2024-2025 | |
| Coopersurgical, INC. | $56.09 | 2022-2025 | Paragard T 380a |
| Sage Therapeutics, LLC | $49.69 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $43.16 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.80 | 2021-2023 | Gardasil 9 |
| Aspira Women'S Health INC | $26.41 | 2024 | Ova1 |
| Shield Therapeutics INC | $24.31 | 2024 | |
| Meditrina | $19.66 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.71 | 2024 | |
| Millicent US INC | $15.68 | 2025 | Femlyv, Intrarosa |
| Myovant Sciences INC. | $15.42 | 2021 | |
| Hologic Sales and Service, LLC | $15.09 | 2019 | |
| Lupin INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mcnamee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.